- Home
- MIRA vs RETO Comparison
MIRA vs RETO Comparison
Compare MIRA & RETO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIRA
- RETO
- Stock Information
- Founded
- MIRA 2020
- RETO 1999
- Country
- MIRA United States
- RETO China
- Employees
- MIRA N/A
- RETO N/A
- Industry
- MIRA Biotechnology: Pharmaceutical Preparations
- RETO Multi-Sector Companies
- Sector
- MIRA Health Care
- RETO Consumer Discretionary
- Exchange
- MIRA Nasdaq
- RETO Nasdaq
- Market Cap
- MIRA 18.4M
- RETO 19.9M
- IPO Year
- MIRA 2023
- RETO 2017
- Fundamental
- Price
- MIRA $1.10
- RETO $0.41
- Analyst Decision
- MIRA Strong Buy
- RETO
- Analyst Count
- MIRA 2
- RETO 0
- Target Price
- MIRA $14.00
- RETO N/A
- AVG Volume (30 Days)
- MIRA 226.5K
- RETO 3.0M
- Earning Date
- MIRA 03-31-2025
- RETO 10-28-2024
- Dividend Yield
- MIRA N/A
- RETO N/A
- EPS Growth
- MIRA N/A
- RETO N/A
- EPS
- MIRA N/A
- RETO N/A
- Revenue
- MIRA N/A
- RETO $3,841,142.00
- Revenue This Year
- MIRA N/A
- RETO N/A
- Revenue Next Year
- MIRA N/A
- RETO N/A
- P/E Ratio
- MIRA N/A
- RETO N/A
- Revenue Growth
- MIRA N/A
- RETO N/A
- 52 Week Low
- MIRA $0.51
- RETO $0.33
- 52 Week High
- MIRA $5.01
- RETO $3.90
- Technical
- Relative Strength Index (RSI)
- MIRA 43.36
- RETO 20.99
- Support Level
- MIRA $1.09
- RETO $0.33
- Resistance Level
- MIRA $1.18
- RETO $0.75
- Average True Range (ATR)
- MIRA 0.06
- RETO 0.09
- MACD
- MIRA -0.00
- RETO -0.01
- Stochastic Oscillator
- MIRA 7.69
- RETO 15.74
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
About RETO ReTo Eco-Solutions Inc.
ReTo Eco-Solutions Inc is a manufacturer and distributor of eco-friendly construction materials and fly-ash, as well as equipment used to produce these eco-friendly construction materials. The company engaged in providing consultation, design, project implementation and construction of urban ecological environments for capturing, controlling and re-using rainwater. It operates through four segments namely Machinery and Equipment sales, Construction materials sales, Municipal Construction Projects, and Technology Consulting and other services. The company earns its revenue from Machinery and Equipment sales segment. Geographically, it derives a majority of its revenue from China.